Bristol-Myers, Ambrx Team Up For Biologics Programs In Diabetes, Heart Failure

22.09.2011 - Bristol-Myers Squibb and Ambrx announced a collaboration under which Bristol-Myers will receive exclusive worldwide rights to research, develop and commercialize biologics based on...